Actos vs. Glimepiride
See how Actos and Glimepiride compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Actos and glimepiride both treat type 2 diabetes but work differently: Actos improves the body's response to insulin, while glimepiride pushes the pancreas to release more insulin.
Glimepiride can cause hypoglycemia on its own; Actos generally does not, but Actos carries a boxed warning for heart failure that glimepiride does not have.
Glimepiride costs a fraction of Actos each month, though both drugs are available in generic form.
Actos vs. Glimepiride Drug Summary
Actos
Actos (pioglitazone) is a thiazolidinedione that helps the body use its own insulin more effectively in adults with type 2 diabetes. It is taken as a single oral tablet once a day, either alone or alongside other diabetes medications. Some doctors also prescribe it off-label for nonalcoholic fatty liver disease.
Glimepiride
Glimepiride is a sulfonylurea that lowers blood sugar by prompting the pancreas to release more insulin. It is taken as a once-daily oral tablet, used together with diet and exercise in adults with type 2 diabetes. It has been available since the 1990s and remains one of the most commonly prescribed generic diabetes drugs.
Actos vs. Glimepiride Side Effects
Actos
Glimepiride
Actos vs. Glimepiride Dosage
Actos
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 15 mg once daily | At the start |
| Maximum dose | 45 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Actos
| STAGE | DOSE | WHEN |
| Starting dose | 15 mg once daily | At the start |
| Maximum dose | 45 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Actos vs. Glimepiride Indications
Actos
Actos is FDA-approved to help control blood sugar in adults with type 2 diabetes, either by itself or combined with other diabetes medicines. It works by making muscle and fat cells more responsive to insulin, rather than increasing the body's insulin supply. Some clinicians also use it off-label for nonalcoholic fatty liver disease (NAFLD/NASH).
Type 2 diabetes as monotherapy
Type 2 diabetes as combination therapy
Off-label: nonalcoholic fatty liver disease/NASH
Not approved for type 1 diabetes or diabetic ketoacidosis
Glimepiride
Glimepiride is FDA-approved as an add-on to diet and exercise for blood sugar control in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin, so it requires some remaining pancreatic function. It has no FDA-approved off-label uses and is not indicated for type 1 diabetes.
Type 2 diabetes, adjunct to diet and exercise
Not approved for type 1 diabetes or diabetic ketoacidosis
No FDA-approved off-label indications
Used alone or combined with insulin or other oral agents
Actos vs. Glimepiride Pros and Cons
Actos
Actos does not cause hypoglycemia on its own, which makes it a useful option for patients who need tighter sugar control without that added risk. It carries a boxed warning for heart failure and should be avoided in patients with significant heart failure, bladder cancer history, or high fracture risk. Its once-daily generic tablet is widely available, though its monthly cost is meaningfully higher than glimepiride's.
Pros
No hypoglycemia risk when used alone
May improve liver fat in off-label NASH use
Available as a low-cost generic tablet
Cons
Boxed warning for heart failure risk
Increased bladder cancer risk with long-term use
Increased fracture risk in women
Roughly $588 to $700 per month before insurance or savings programs
Glimepiride
Glimepiride is one of the least expensive oral diabetes medications available, which makes it accessible for many patients without insurance. Its main risk is hypoglycemia, especially in older adults or people with irregular eating patterns, and older studies raised concerns about cardiovascular mortality with sulfonylureas as a class. It also requires functioning pancreatic beta cells, so its effectiveness can decline over time.
Pros
Roughly $10 to $20 per month, one of the cheapest options
Long track record of use since 1995
Rapid onset of blood sugar lowering
Cons
Can cause significant hypoglycemia
Possible increased cardiovascular mortality risk (class effect)
Risk of hemolytic anemia in G6PD deficiency
Effectiveness may decline as pancreatic function decreases
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.